Insider Transactions in Q1 2024 at Protara Therapeutics, Inc. (TARA)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 19
2024
|
Hannah Fry VP, Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
904
-2.94%
|
$904
$1.91 P/Share
|
|
Jan 19
2024
|
Hannah Fry VP, Controller |
BUY
Grant, award, or other acquisition
|
Direct |
8,000
+20.65%
|
-
|
|
Jan 19
2024
|
Patrick Fabbio Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
22,000
+50.0%
|
-
|
|
Jan 19
2024
|
Jacqueline Zummo Chf Scientific Operations Off |
SELL
Payment of exercise price or tax liability
|
Direct |
3,049
-2.84%
|
$3,049
$1.91 P/Share
|
|
Jan 19
2024
|
Jacqueline Zummo Chf Scientific Operations Off |
BUY
Grant, award, or other acquisition
|
Direct |
23,000
+17.65%
|
-
|
|
Jan 19
2024
|
Jathin Bandari Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,879
-4.83%
|
$2,879
$1.91 P/Share
|
|
Jan 19
2024
|
Jathin Bandari Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
23,000
+27.85%
|
-
|
|
Jan 19
2024
|
Jesse Shefferman CEO and President |
SELL
Payment of exercise price or tax liability
|
Direct |
7,803
-0.82%
|
$7,803
$1.91 P/Share
|
|
Jan 19
2024
|
Jesse Shefferman CEO and President |
BUY
Grant, award, or other acquisition
|
Direct |
59,000
+5.84%
|
-
|
|
Jan 10
2024
|
Jathin Bandari Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,877
-4.88%
|
$3,754
$2.39 P/Share
|
|
Jan 10
2024
|
Jacqueline Zummo Chf Scientific Operations Off |
SELL
Payment of exercise price or tax liability
|
Direct |
5,229
-5.84%
|
$10,458
$2.39 P/Share
|
|
Jan 10
2024
|
Jesse Shefferman CEO and President |
SELL
Payment of exercise price or tax liability
|
Direct |
5,746
-0.64%
|
$11,492
$2.39 P/Share
|
|
Jan 03
2024
|
Jacqueline Zummo Chf Scientific Operations Off |
SELL
Payment of exercise price or tax liability
|
Direct |
1,899
-2.08%
|
$3,798
$2.17 P/Share
|
|
Jan 03
2024
|
Jesse Shefferman CEO and President |
SELL
Payment of exercise price or tax liability
|
Direct |
5,840
-0.65%
|
$11,680
$2.17 P/Share
|
|
Jan 03
2024
|
Hannah Fry VP, Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
324
-1.4%
|
$648
$2.17 P/Share
|